Research map: Family planning and multiple sclerosis – part 2: Does real-world practice align with Swedish treatment guidelines?

Back to the article

Papers in this map

  1. Rituximab before and during pregnancy · Gitanjali Das · 2018 · 220 citations · Cited by this paper
  2. Comorbidities in newly diagnosed multiple sclerosis patients: A population-based register study in Finland · 2026 · Related
  3. Family planning considerations in people with multiple sclerosis · Kristen M. Krysko · 2023 · 134 citations · Cited by this paper
  4. Hypogammaglobulinemia and infection rates in patients with multiple sclerosis treated with ocrelizumab for up to six years: A real-world single-center study · 2025 · Related
  5. Rapidly increasing off-label use of rituximab in multiple sclerosis in Sweden - Outlier or predecessor? · Shala Ghaderi Berntsson · 2018 · 68 citations · Cited by this paper
  6. Real-world safety and effectiveness of ofatumumab in multiple sclerosis: A clinic-based study in Australia · 2026 · Related
  7. A systematic review and meta-analyses of pregnancy and fetal outcomes in women with multiple sclerosis: a contribution from the IMI2 ConcePTION project · Sandra López‐León · 2020 · 53 citations · Cited by this paper
  8. Men's health research priorities in men with multiple sclerosis · 2026 · Related
  9. Pregnancy and multiple sclerosis: an update · Guoda Varytė · 2021 · 52 citations · Cited by this paper
  10. Music therapy with a monochord in multiple sclerosis (“MUTIMS”): A randomized, controlled, rater-blinded trial · 2025 · Related
  11. Patient awareness about family planning represents a major knowledge gap in multiple sclerosis · Peter Vestergaard Rasmussen · 2018 · 44 citations · Cited by this paper
  12. Deep cervical lymph node volume decreases following B-cell depletion therapy · 2025 · Related
  13. Disease activity in pregnancy and postpartum in women with MS who suspended rituximab and natalizumab · Neda Razaz · 2020 · 36 citations · Cited by this paper
  14. Establishing demographic-based normative values for neurofilament light chain and glial fibrillary acidic protein in serum and plasma samples · 2026 · Related
  15. Fertility, pregnancy and childbirth in women with multiple sclerosis: a population-based study from 2018 to 2020 · Marcello Moccia · 2023 · 32 citations · Cited by this paper
  16. Feasibility and preliminary outcomes of a remotely-delivered exercise training intervention for English-speaking Hispanics/Latinos with multiple sclerosis: Results from the FERLA MS study · 2026 · Related
  17. Impact of disease-modifying therapies on pregnancy outcomes in multiple sclerosis: a prospective cohort study from the German multiple sclerosis and pregnancy registry · Nadine Bast · 2024 · 24 citations · Cited by this paper
  18. Discrepancy between subjective and objective cognitive function in multiple sclerosis and association with mood, fatigue, and pain · 2026 · Related
  19. Real‐World Healthcare Cost Savings and Reduced Relapse Rate with Off‐Label Rituximab versus Disease‐Modifying Treatments Approved for Relapsing–Remitting Multiple Sclerosis: A Nationwide Cost‐Effectiveness Study · Peter Alping · 2024 · 18 citations · Cited by this paper
  20. Baricitinib triggering a central nervous system inflammatory-demyelinating disease: A case report · 2026 · Related
  21. Prevalence of adverse pregnancy outcomes after exposure to interferon beta prior to or during pregnancy in women with MS: Stratification by maternal and newborn characteristics in a register-based cohort study in Finland and Sweden · Marta Korjagina · 2020 · 16 citations · Cited by this paper

Source: OpenAlex (CC0)